D-0155-2018 Class II Terminated
FDA drug recall D-0155-2018 was initiated by Solco Healtcare US LLC on Dec 4, 2017 and is designated Class II. Reason for recall: Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg The recall status is terminated (terminated Feb 25, 2019).
Recall details
- Product Type
- Drugs
- Report Date
- Jan 17, 2018
- Initiation Date
- Dec 4, 2017
- Termination Date
- Feb 25, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50
Reason for recall
Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg
Distribution pattern
Product was distributed in Mason, OH.
Code information
Lot # 7700656A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0155-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026